OTO-IVM is a method of fertility preservation for patients with ovarian tumors
Open Access
- 9 September 2024
- journal article
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 23 (4) , 96-107
Abstract
Introduction. An increasing number of patients of reproductive age get cancer and are highly interested in preserving fertility. Survival rates for cancer patients are improving. Methods of reproductive technologies are being improved to preserve the ability to bear children. Rehabilitation aimed to ensure a satisfactory quality of life takes on a new meaning, and with the development of new technologies, the level of possible assistance also changes. Today, rehabilitation measures for cancer patients of reproductive age should undoubtedly include all possible ways to preserve and restore fertility. Aim: preservation of fertility in patients with ovarian tumors. Material and Methods. After ovariectomy, the ovaries were transported to the embryology laboratory, where oocyte-cumulus complexes were extracted and subsequently matured using the OTO-IVM (ovarian tissue oocyte in vitro maturation) method. The resulting mature oocytes (Metaphase II) were cryopreserved by vitrification or, if a partner was available, fertilized by ICSI (intracytoplasmic sperm injection), the embryos were cultured to the blastocyst stage and also cryopreserved by vitrification. Cryopreserved oocytes and embryos can be used by patients after cancer treatment in assisted reproductive technology programs. Results. A total of 218 OCCs were recovered, 29.8 % were degraded oocytes (n=65). The proportion of OCC suitable for ripening was 153 (70.2 %). After 36 or 48 hours, 65 oocytes matured in 13 patients, which amounted to 42.5 % of oocytes without signs of degradation. In 11 patients the OCC was removed from the tumor-affected ovary. 149 oocytes were obtained, of which 50 (33.6 %) were oocytes with signs of degradation. The remaining 99 (66.4 %) of OCCs had satisfactory quality; after maturation, the Metaphase II stage reached in 49 (49.5 %) of oocytes. As a result, biological material was cryopreserved in 13 of 15 patients: 5 embryos and 60 oocytes.Keywords
This publication has 37 references indexed in Scilit:
- The experiences of reproductive concerns in cancer survivors: A systematic review and meta‐synthesis of qualitative studiesCancer Medicine, 2023
- Is in vitro maturation of oocytes retrieved ex vivo from ovarian tissue an effective fertility preservation technique in the presence of organic ovarian cysts?European Journal of Obstetrics & Gynecology and Reproductive Biology, 2022
- Annual report to the nation on the status of cancerCancer, 2022
- Reproductive concerns among adolescent and young adult cancer survivors: A scoping review of current research situationsCancer Medicine, 2022
- Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†Annals of Oncology, 2020
- Fertility under uncertainty: exploring differences in fertility-related concerns and psychosocial aspects between breast cancer survivors and non-cancer infertile womenBreast Cancer, 2020
- Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservationJournal of Assisted Reproduction and Genetics, 2018
- Young adult female cancer survivors' unmet information needs and reproductive concerns contribute to decisional conflict regarding posttreatment fertility preservationCancer, 2016
- Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the futureCancer, 2016
- Experiencing reproductive concerns as a female cancer survivor is associated with depressionCancer, 2014